BlueDot

BlueDot

BlueDot is a Toronto-based AI company that tracks, contextualizes and anticipates infectious disease risks. Their products aim to help governments, hospitals and businesses protect employees and customers.

All edits by  Julius John Villarisco 

Edits on 18 September, 2019
Julius John Villarisco"Approved suggestion from source: https://betakit.com/bluedot-announces-second-series-a-round-this-time-worth-9-2-million-cad/"
Julius John Villarisco approved a suggestion from Golden's AI on 18 September, 2019 6:18 am
Edits made to:
Timeline (+1 events) (+166 characters)
Timeline

2014

BlueDot is calling the round its Series A, despite the fact that this latest funding round comes five years after the company announced a different Series A, in 2014.

Edits on 17 September, 2019
Julius John Villarisco"Approved suggestion from source: https://betakit.com/bluedot-announces-second-series-a-round-this-time-worth-9-2-million-cad/"
Julius John Villarisco approved a suggestion from Golden's AI on 17 September, 2019 7:52 am
Edits made to:
Timeline (+1 events) (+583 characters)
Timeline

August 7, 2019

BlueDot announces second Series A round, this time worth $9.2 million CAD | BetaKit

However, BlueDot recently told BetaKit that calling its round a Series A was "a misclassification of our seed round," and it now considers the funding seed because of the amount that was invested ($2.5 million USD), as well as that the capital "was intended to help us fund the development of our technology, secure initial traction, and build our team.

Prior to that original Series A, BlueDot had already received $500,000 in, ( what MaRS called), seed funding, which BlueDot now considers pre-seed.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.